The impact that certain diets, foods, ingredients or nutrients have on cognitive decline or Alzheimer’s risk is notoriously difficult to study. But, while there…
Soybean oil — a vegetable oil made from soybean seeds — is one of the most popular types of oils consumed in the U.S.,…
A new study by Houston Methodist scientists finds that a protein linked to ovarian cancer may contribute to the development of Alzheimer’s disease. The…
In a new study, scientists have tested an experimental drug in mice that may hold promise for future Alzheimer’s treatments. The drug involves a…
Early detection of dementia and Alzheimer’s disease can help patients get the care and help they need sooner rather than later, but there is…
The well-known factors that contribute to the development of dementia include genetics, age, lifestyle and even environment. But more and more research is pointing…
Biogen has agreed to buy an experimental Alzheimer’s and Parkinson’s treatment from Pfizer, the company announced Monday. In the agreed deal, Biogen will pay…
While researchers are looking into new forms of medicinal solutions to dementia, more and more attention is being paid to lifestyle-focused approaches to the…
Being Patient spoke with Kaitlin Casaletto, a neuropsychologist and assistant professor at UCSF Memory and Aging Center, about the results of her study on…
Pulling an all-nighter or getting fewer hours of sleep than normal may have more consequences than simply suffering fatigue during the work day. According…
Scientists are continuing to search for answers to Alzheimer’s disease and other dementias, targeting beta-amyloid and tau protein, inflammation, and genetic factors in research…
When it comes to Alzheimer’s, what happens first: beta amyloid plaques, or the visible personality and cognitive changes common with the disease? Researchers have…
If you needed more motivation to get moving in the new year, a new study provides more evidence that exercise can help keep your…
Much of Alzheimer’s research has focused on beta-amyloid plaques, one of the main drivers behind neurodegeneration in people with dementia. But more and more…
An experimental “seaweed” drug called Oligomannate, which treats Alzheimer’s, is now available for patients to buy in China. Chinese officials announced conditional approval to…